GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment
The potency of GIGA-2339 is claimed to be more than 2,000 times greater than that of plasma-derived HBV treatments.
Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (3)
Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...
Grifols says potential Brookfield offer ‘significantly undervalues’ shares
Grifols (GRFS) informs that its board has held an extraordinary meeting this afternoon “without the intervention of the conflicted board ...
Grifols Board Issues Unfavorable Opinion on Brookfield Offer
Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...
Grifols slips as board rebuffs Brookfield’s $6.8B offer (update)
ADRs fell ~6% on Tuesday after its board of directors declined to recommend Brookfield Asset Management's (NYSE:BAM) ...
Grifols: Brookfield's potential $6.8 billion offer undervalues the firm
Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer ...
Spain Court Opens Probe Into 'Misleading' US Hedge Fund
A Spanish court on Tuesday said it was investigating the US hedge fund Gotham City for allegedly publishing "misleading" information about Spanish pharmaceutical firm Grifols, causing its shares to ...
Grifols doses first patient in Phase 1 trial of GIGA-2339
GigaGen announced that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of the first ...
Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop
Brookfield Asset Management is considering a €6.45 billion ($6.9 billion) bid for Grifols SA, with the drug maker’s board set ...
Spanish court opens investigation into Gotham City's attack on Grifols
An investigating magistrate at the Spanish High Court said on Tuesday it had opened an investigation into U.S.-based short ...
TMCnet1d
Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors
Mason Capital Management LLC is an absolute return focused investment firm that combines deep fundamental analysis with hard catalysts to drive value creation. Founded in July 2000 by Ken Garschina ...